SCHEMBL23716362

SCHEMBL23716362

CC(C)=C/C=C(\N)Cc1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TRPV1 Q8NER1 2/20 0.38
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
HTR3A P46098 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
SLC6A2 P23975 2/20 0.37
SLC6A3 Q01959 2/20 0.37
HTR2A P28223 1/20 0.37
SLC6A4 P31645 1/20 0.37
HRH1 P35367 1/20 0.37
HTR2B P41595 1/20 0.37
CHRNA4 P43681 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23716034 0.87 IDO1 (0.38) IDO1L3MBTL1NPC1RAB9AHTR3E
SCHEMBL23716096 0.86 IDO1 (0.37) IDO1L3MBTL1NPC1RAB9AHTR3E
SCHEMBL23715988 0.83 IDO1 (0.40) IDO1L3MBTL1NPC1RAB9ALMNA
SCHEMBL23716227 0.82 GABRA1 (0.40) IDO1L3MBTL1NPC1RAB9AHTR3E
SCHEMBL23715780 0.81 IDO1 (0.42) IDO1LMNATAAR1
SCHEMBL23716015 0.78 PTPN7 (0.34) IDO1L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL27760048 0.76 IDO1 (0.47) IDO1L3MBTL1NPC1RAB9AHTR3E
SCHEMBL23716379 0.73 IDO1 (0.38) IDO1L3MBTL1NPC1RAB9ALMNA
SCHEMBL23716069 0.73 DHFR (0.36) SMN1; SMN2
SCHEMBL433511 0.71 NPC1 (0.48) IDO1L3MBTL1NPC1RAB9ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3209732-B1 SPHINGOSINE-1-PHOSPATE RECEPTOR MODULATORS FOR TREATMENT OF CARDIOPULMONARY DISORDERS SCRIPPS RESEARCH INST (US) 2021-08-04 EP disclosed